Lipid nanoparticles linked with anti-TPSAB1 antibodies represent a groundbreaking strategy in combating colorectal cancer by specifically targeting the TPSAB1 protein, which is implicated in tumor progression. This novel approach not only facilitates enhanced recognition of cancer cells by the immune system but also promotes their rapid clearance, potentially leading to improved patient outcomes. By harnessing the power of targeted therapy, this innovative combination significantly increases the overall efficacy of colorectal cancer treatments, offering new hope for those affected by this disease.
Download resources about recombinant antibody development and antibody engineering to boost your research.
Select a product category from the dropdown menu below to view related products.
CAT | Product Name | Application | Type |
---|---|---|---|
MOB-0322MZ | Recombinant Mouse Anti-Human TPSAB1 Antibody (clone BA2) | IHC | Mouse antibody |
MRO-0968-CN | Rabbit Anti-TPSAB1 Recombinant Antibody (clone CBACN-354) | WB, IHC, IP | Rabbit IgG |
VS3-FY1479 | Recombinant Mouse Anti-TPSAB1 Antibody (clone 6B6B12) | ELISA, IHC, FC | Mouse IgG2b |
VS3-FY1480 | Recombinant Mouse Anti-TPSAB1 Antibody (clone 1B2E6) | ELISA, IHC, ICC, FC | Mouse IgG1 |
VS3-FY1481 | Recombinant Mouse Anti-TPSAB1 Antibody (clone 7C4-3H6-1E9) | IHC-P | Mouse IgG1 |
There are currently no Customer reviews or questions for VS-1024-FY152. Click the button above to contact us or submit your feedback about this product.
For Research Use Only. Not For Clinical Use.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.